1970s: Point of origin: technical Cisplatin as homogeneous catalysts for polysiloxane production
1982: Start of commercial Cisplatin production for pharmaceutical application
1987: Beginning of Carboplatin production
1988: First FDA Inspection confirming cGMP status of Heraeus API production
1996: Initial FDA approval for Cisplatin
2000: General FDA approval as manufacturer of synethetic, non-sterile APIs
2003: FDA approval for Carboplatin
2003: New building for R&D and production under operation
2007: Successful FDA audit for various products
2009: Launch of our new multi-purpose production plant and commercial fermentation facility for hAPIs
